Can you provide the average price target for EXOSENS SAS stock?
19 analysts have analysed EXENS.PA and the average price target is 65.31 EUR. This implies a price increase of 0.71% is expected in the next year compared to the current price of 64.85.
EPA:EXENS • FR001400Q9V2
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EXOSENS SAS (EXENS.PA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-12 | Berenberg | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 291.819M 45.36% | 383.441M 31.40% | 468.187M 22.10% | 551.49M 17.79% | 626.9M 13.67% | 709.61M 13.19% | 782.47M 10.27% | 874.79M 11.80% | 826.96M -5.47% | 876.54M 6.00% | 929.12M 6.00% | |
| EBITDA YoY % growth | 80.53M 62.12% | 109.91M 36.48% | 146.512M 33.30% | 175.51M 19.79% | 204.74M 16.65% | 236.62M 15.57% | 279.81M 18.25% | 319.57M 14.21% | N/A | N/A | N/A | |
| EBIT YoY % growth | 49.598M 70.29% | 75.303M 51.83% | 106.988M 42.08% | 137.19M 28.23% | 163.48M 19.16% | 188.64M 15.39% | 234.48M 24.30% | 275.82M 17.63% | N/A | N/A | N/A | |
| Operating Margin | 17.00% | 19.64% | 22.85% | 24.88% | 26.08% | 26.58% | 29.97% | 31.53% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A 50.07% | 1.95 30.89% | 2.29 17.69% | 2.74 19.83% | 3.30 20.24% | 3.81 15.53% | N/A | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
19 analysts have analysed EXENS.PA and the average price target is 65.31 EUR. This implies a price increase of 0.71% is expected in the next year compared to the current price of 64.85.
EXOSENS SAS (EXENS.PA) will report earnings on 2026-04-27.
The expected long term growth rate for EXOSENS SAS (EXENS.PA) is 14.18%.